What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Gene
Michael Heberer mainly investigates Tissue engineering, Cartilage, Chondrocyte, Immunology and Cell biology.
Michael Heberer has included themes like Biomaterial, Ex vivo, Cell culture and Tissue culture in his Tissue engineering study.
His Cartilage study also includes fields such as
- Glycosaminoglycan, which have a strong connection to Chondrogenesis, Scaffold and Growth factor,
- Extracellular matrix which intersects with area such as Gene expression and Molecular biology.
His Chondrocyte research integrates issues from Cartilaginous Tissue and Type II collagen.
His CTL*, Cytokine, CXCL10 and Chemokine study, which is part of a larger body of work in Immunology, is frequently linked to Defective virus, bridging the gap between disciplines.
The concepts of his Biomedical engineering study are interwoven with issues in Cell, Stromal cell and In vivo.
His most cited work include:
- The role of bioreactors in tissue engineering. (904 citations)
- Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. (442 citations)
- Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro (404 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Immunology, Molecular biology, Cytotoxic T cell, Antigen and Internal medicine.
His Immunology research is multidisciplinary, incorporating elements of Progenitor cell, Melanoma and Cell biology.
His Cell biology study incorporates themes from Chondrocyte and Type II collagen.
In his research on the topic of Molecular biology, Cell growth is strongly related with Cell culture.
His biological study spans a wide range of topics, including Cancer research, CD8 and Immunotherapy.
Michael Heberer has researched Antigen in several fields, including Immunohistochemistry, Pathology and Virology.
He most often published in these fields:
- Immunology (20.80%)
- Molecular biology (19.20%)
- Cytotoxic T cell (18.40%)
What were the highlights of his more recent work (between 2011-2019)?
- Cancer research (15.60%)
- Pathology (13.20%)
- Angiogenesis (8.40%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cancer research, Pathology, Angiogenesis, Colorectal cancer and Cell biology.
He combines subjects such as Cell, Cancer cell, Carcinogenesis, Immunology and In vivo with his study of Cancer research.
His work often combines Immunology and Population studies.
His research integrates issues of Cell culture, Cell growth, Apoptosis, Molecular biology and Cytotoxic T cell in his study of In vivo.
His Angiogenesis research incorporates elements of Myocyte, Vascular endothelial growth factor A, Vascular endothelial growth factor and Platelet-derived growth factor receptor.
Michael Heberer studies Cell biology, focusing on Mesenchymal stem cell in particular.
Between 2011 and 2019, his most popular works were:
- Clinical impact of programmed cell death ligand 1 expression in colorectal cancer. (275 citations)
- Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial (101 citations)
- High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor (60 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Gene
Pathology, Angiogenesis, Cell biology, Cancer research and Mesenchymal stem cell are his primary areas of study.
As part of the same scientific family, Michael Heberer usually focuses on Pathology, concentrating on Colorectal cancer and intersecting with Immune system, Antigen, CD8, Lymph node and PD-L1.
His Cancer research study combines topics from a wide range of disciplines, such as Cell and In vivo.
His studies in In vivo integrate themes in fields like Cancer cell and Molecular biology.
His Mesenchymal stem cell research includes elements of Stromal cell, Bone cell, Stem cell and Bone healing.
He interconnects Immunology and Fibroblast growth factor in the investigation of issues within Stromal cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
